- Lidocaine jelly, topical, 2 g/100mL.
- For urethral catheterisation: female 5–7 mL, male 10–15 mL.
- Lidocaine topical spray, 4%.
- Maximum dose 160 mg.
- To assist with awake intubation or reduce haemodynamic response to intubation.
For venepuncture analgesia in adults or oncology patients requiring repeated invasive procedures (e.g. lumbar punctures, venepuncture):
- Lidocaine/prilocaine, topical cream, 2.5/2.5%.
- Apply at least 1 hour before and cover with occlusive dressing.